The SGLT2 inhibitor Tofogliflozin prevents the progression of nonalcoholic steatohepatitis-associated liver tumors in a novel murine model

Naoki Yoshioka

6:40 PM - 6:50 PM

[1T14e-11(P-800)] The SGLT2 inhibitor Tofogliflozin prevents the progression of nonalcoholic steatohepatitis-associated liver tumors in a novel murine model

^○Naoki Yoshioka^1,2, Miyako Tanaka¹, Kozue Ochi¹, Akiko Watanabe¹, Michiko Itoh^3,4, Masatoshi Ishigami², Mitsuhiro Fujishiro², Takayoshi Suganami¹ (1.Department of Molecular Medicine and Metabolism, Research Institute of Environmental Medicine, Nagoya University, 2.Department of Gastroenterology and Hepatology, Nagoya University Graduate School of Medicine, 3.Kanagawa Institute of Industrial Science and Technology, 4.Department of Metabolic Syndrome and Nutritional Science, Research Institute of Environmental Medicine, Nagoya University)

キーテクノロジー：疾患動物モデル

肝がん、非アルコール性脂肪肝炎、肥満、糖尿病、SGLT2阻害薬

Contents of this site has moved to the member page of The Japanese Biochemical Society: https://member.jbsoc.or.jp/mypage/
You can access the abstracts without credentials by accessing them via the member page.

You need the membership number and password to access the member page. Please contact the journal office for any inquiries.

Journal Office Contact Information:
E-mail:jbs-ho@jbsoc.or.jp
Tel:03(3815)1913 Fax:03(3815)1934

The 94th Annual Meeting of JBS

[1T14e-11(P-800)] The SGLT2 inhibitor Tofogliflozin prevents the progression of nonalcoholic steatohepatitis-associated liver tumors in a novel murine model

Password